Literature DB >> 14742369

The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity.

Chun-Su Yuan1, Sangeeta Mehendale, Yingping Xiao, Han H Aung, Jing-Tian Xie, Michael K Ang-Lee.   

Abstract

UNLABELLED: Valerian is a medicinal herb that produces anxiolytic and sedative effects. It was suggested that valerian acts via gamma-aminobutyric acid (GABA)ergic mechanisms. Previous studies showed binding of valerian extract to GABA receptors, but the functional effect of the binding has not been demonstrated. In this study we evaluated the GABAergic effect of valerian extract and one of its major constituents, valerenic acid, on brainstem neuronal activity in an in vitro neonatal rat brainstem preparation. We first observed that muscimol, a GABA(A) receptor agonist, decreased the firing rate in most brainstem neurons in a concentration-related fashion; 30 micro M produced a 38.9% +/- 3.0% (mean +/- SE) inhibition compared with control values (P < 0.01; 50% inhibitory concentration [IC(50)], 2.0 +/- 0.1 microM). This effect was antagonized by bicuculline (10 microM), a GABA(A) antagonist. Then we showed that valerian extract 3 mg/mL induced a 29.6% +/- 5.1% inhibition with an IC(50) of 240 +/- 18.7 microg/mL, whereas 100 microM valerenic acid induced a 22.2% +/- 3.4% inhibition with an IC(50) of 23 +/- 2.6 microM (both P < 0.01). Bicuculline antagonized the inhibitory effects of both the valerian extract and valerenic acid. In addition, pretreatment with valerian extract or valerenic acid decreased the brainstem inhibitory effects produced by muscimol (both P < 0.05), suggesting that these compounds play an important role in the regulation of GABAergic activity. Data from this study suggest that the pharmacological effects of valerian extract and valerenic acid are mediated through modulation of GABA(A) receptor function. Thus, valerian may potentiate the sedative effects of anesthetics and other medications that act on GABA receptors, and presurgical valerian use may cause a valerian-anesthetic interaction. IMPLICATIONS: Valerian is an herb used in treating anxiety and insomnia. We observed that the valerian effects are mediated through brain gamma-aminobutyric acid (GABA) receptors in a rat brainstem preparation. Thus, valerian may potentiate the effects of anesthetics that act on GABA receptors, and presurgical valerian use may cause a valerian-anesthetic interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742369     DOI: 10.1213/01.ane.0000096189.70405.a5

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  21 in total

Review 1.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

2.  Herbal medicines as adjuvants for cancer therapeutics.

Authors:  Chong-Zhi Wang; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2012       Impact factor: 4.667

3.  Valeriana officinalis Extracts Ameliorate Neuronal Damage by Suppressing Lipid Peroxidation in the Gerbil Hippocampus Following Transient Cerebral Ischemia.

Authors:  Dae Young Yoo; Hyo Young Jung; Sung Min Nam; Jong Whi Kim; Jung Hoon Choi; Youn-Gil Kwak; Miyoung Yoo; Sanghee Lee; Yeo Sung Yoon; In Koo Hwang
Journal:  J Med Food       Date:  2015-03-18       Impact factor: 2.786

4.  Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Authors:  Birgit M Dietz; Gail B Mahady; Guido F Pauli; Norman R Farnsworth
Journal:  Brain Res Mol Brain Res       Date:  2005-08-18

Review 5.  Management of anxiety and sleep disorders: role of complementary and alternative medicine and challenges of integration with conventional orthodox care.

Authors:  Martins Ekor; Oluyomi S Adeyemi; Chiagoziem A Otuechere
Journal:  Chin J Integr Med       Date:  2012-12-29       Impact factor: 1.978

6.  Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors.

Authors:  Lisa M Del Valle-Mojica; José M Cordero-Hernández; Giselle González-Medina; Igmeris Ramos-Vélez; Nairimer Berríos-Cartagena; Bianca A Torres-Hernández; José G Ortíz
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-02       Impact factor: 2.629

7.  HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes.

Authors:  Hyun Jung Kim; Igor Baburin; Sophia Khom; Steffen Hering; Matthias Hamburger
Journal:  Planta Med       Date:  2008-04       Impact factor: 3.352

Review 8.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04

9.  Evaluation of Behavioral and Pharmacological Effects of Hydroalcoholic Extract of Valeriana prionophylla Standl. from Guatemala.

Authors:  Iandra Holzmann; Valdir Cechinel Filho; Ticiana C Mora; Armando Cáceres; Jose Vicente Martínez; Sully M Cruz; Márcia Maria de Souza
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-30       Impact factor: 2.629

10.  A Valepotriate Fraction of Valeriana glechomifolia Shows Sedative and Anxiolytic Properties and Impairs Recognition But Not Aversive Memory in Mice.

Authors:  Natasha Maurmann; Gustavo Kellermann Reolon; Sandra Beatriz Rech; Arthur Germano Fett-Neto; Rafael Roesler
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.